GlaxoSmithKline said to be eyeing £1 billion plus takeover bid for Theravance Biopharma, reports The Times - Betaville.co.ukFriday, 11 February 2022 8:21 amHas GlaxoSmithKline given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer? 